BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26130569)

  • 1. The role of miR-100 in regulating apoptosis of breast cancer cells.
    Gong Y; He T; Yang L; Yang G; Chen Y; Zhang X
    Sci Rep; 2015 Jul; 5():11650. PubMed ID: 26130569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA-24-3p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting p27Kip1.
    Lu K; Wang J; Song Y; Zhao S; Liu H; Tang D; Pan B; Zhao H; Zhang Q
    Oncol Rep; 2015 Aug; 34(2):995-1002. PubMed ID: 26044523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propofol induces apoptosis of breast cancer cells by downregulation of miR-24 signal pathway.
    Yu B; Gao W; Zhou H; Miao X; Chang Y; Wang L; Xu M; Ni G
    Cancer Biomark; 2018 Feb; 21(3):513-519. PubMed ID: 29103019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-874 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting CDK9.
    Wang L; Gao W; Hu F; Xu Z; Wang F
    FEBS Lett; 2014 Dec; 588(24):4527-35. PubMed ID: 25281924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
    Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
    Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
    Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA-205 affects infiltration and metastasis of breast cancer.
    Wang Z; Liao H; Deng Z; Yang P; Du N; Zhanng Y; Ren H
    Biochem Biophys Res Commun; 2013 Nov; 441(1):139-43. PubMed ID: 24129185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
    Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
    Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The miR-15 family enhances the radiosensitivity of breast cancer cells by targeting G2 checkpoints.
    Mei Z; Su T; Ye J; Yang C; Zhang S; Xie C
    Radiat Res; 2015 Feb; 183(2):196-207. PubMed ID: 25594541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of miR-100-mediated Notch pathway in apoptosis of gastric tumor cells.
    Yang G; Gong Y; Wang Q; Wang Y; Zhang X
    Cell Signal; 2015 Jun; 27(6):1087-101. PubMed ID: 25703026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1.
    Bao C; Chen J; Chen D; Lu Y; Lou W; Ding B; Xu L; Fan W
    Cell Death Dis; 2020 Aug; 11(8):618. PubMed ID: 32796817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
    Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
    Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
    Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
    Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway.
    Wang X; Qiu W; Zhang G; Xu S; Gao Q; Yang Z
    Int J Clin Exp Pathol; 2015; 8(5):5017-25. PubMed ID: 26191195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27(kip1) expression.
    Wang DD; Li J; Sha HH; Chen X; Yang SJ; Shen HY; Zhong SL; Zhao JH; Tang JH
    Gene; 2016 Sep; 590(1):44-50. PubMed ID: 27282281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression.
    Deng X; Zhao Y; Wang B
    Oncol Rep; 2015 Oct; 34(4):2188-94. PubMed ID: 26238950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
    Yang G; Wu D; Zhu J; Jiang O; Shi Q; Tian J; Weng Y
    Oncol Rep; 2013 Aug; 30(2):877-89. PubMed ID: 23760062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
    Zhang HD; Sun DW; Mao L; Zhang J; Jiang LH; Li J; Wu Y; Ji H; Chen W; Wang J; Ma R; Cao HX; Wu JZ; Tang JH
    Biochem Biophys Res Commun; 2015 Oct; 465(4):702-13. PubMed ID: 26299922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-185 is involved in human breast carcinogenesis by targeting Vegfa.
    Wang R; Tian S; Wang HB; Chu DP; Cao JL; Xia HF; Ma X
    FEBS Lett; 2014 Nov; 588(23):4438-47. PubMed ID: 25448984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.